Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice
- PMID: 27491335
- PMCID: PMC4974561
- DOI: 10.1038/srep31130
Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice
Abstract
Atherosclerosis is a chronic inflammatory disease characterized by formation of lipid-rich plaques on the inner walls of arteries. ADAMTS4 (a disintegrin-like and metalloproteinase with thrombospondin motifs-4) is a secreted proteinase that regulates versican turnover in the arterial wall and atherosclerotic plaques. Recent reports indicated elevated ADAMTS4 level in human atherosclerotic plaques and in the plasma of acute coronary syndrome patients. Nevertheless, whether increased ADAMTS4 is a consequence of atherosclerosis or ADAMTS4 has a causal role in atherogenesis remains unknown. In this work, we investigated the role of ADAMTS4 in diet induced atherosclerosis using apolipoprotein E deficient (ApoE(-/-)) and Adamts4 knockout mice. We show that ADAMTS4 expression increases in plaques as atherosclerosis progresses in ApoE(-/-) mice. ApoE(-/-)Adamts4(-/-) double knockout mice presented a significant reduction in plaque burden at 18 weeks of age. Loss of ADAMTS4 lead to a more stable plaque phenotype with a significantly reduced plaque vulnerability index characterized by reduced lipid content and macrophages accompanied with a significant increase in smooth muscle cells, collagen deposition and fibrotic cap thickness. The reduced atherosclerosis is accompanied by an altered plasma inflammatory cytokine profile. These results demonstrate for the first time that ADAMTS4 contributes to diet induced atherosclerosis in ApoE(-/-) mice.
Figures








Similar articles
-
Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.Circulation. 2016 Jun 7;133(23):2263-78. doi: 10.1161/CIRCULATIONAHA.116.021805. Epub 2016 May 6. Circulation. 2016. PMID: 27154724 Free PMC article.
-
NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.J Cardiovasc Pharmacol. 2016 Mar;67(3):203-11. doi: 10.1097/FJC.0000000000000334. J Cardiovasc Pharmacol. 2016. PMID: 26485209
-
Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):60-8. doi: 10.1161/ATVBAHA.115.306397. Epub 2015 Nov 12. Arterioscler Thromb Vasc Biol. 2016. PMID: 26564821 Free PMC article.
-
Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.J Cell Mol Med. 2014 Apr;18(4):721-34. doi: 10.1111/jcmm.12221. Epub 2014 Jan 30. J Cell Mol Med. 2014. PMID: 24479820 Free PMC article.
-
Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2306-15. doi: 10.1161/ATVBAHA.113.302028. Epub 2013 Jul 25. Arterioscler Thromb Vasc Biol. 2013. PMID: 23887640
Cited by
-
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction.Cardiovasc Res. 2023 Aug 19;119(10):1915-1927. doi: 10.1093/cvr/cvad078. Cardiovasc Res. 2023. PMID: 37216909 Free PMC article.
-
Atherosclerosis Pathways are Activated in Pericoronary Adipose Tissue of Patients with Coronary Artery Disease.J Inflamm Res. 2021 Oct 20;14:5419-5431. doi: 10.2147/JIR.S326769. eCollection 2021. J Inflamm Res. 2021. PMID: 34707383 Free PMC article.
-
A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.J Atheroscler Thromb. 2018 May 1;25(5):439-453. doi: 10.5551/jat.40956. Epub 2017 Nov 22. J Atheroscler Thromb. 2018. PMID: 29162773 Free PMC article.
-
A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice.Front Immunol. 2023 Jan 25;14:1114802. doi: 10.3389/fimmu.2023.1114802. eCollection 2023. Front Immunol. 2023. PMID: 36761778 Free PMC article.
-
High molecular weight hyaluronan protects cartilage from degradation by inhibiting aggrecanase expression.J Orthop Res. 2018 Dec;36(12):3247-3255. doi: 10.1002/jor.24126. Epub 2018 Sep 7. J Orthop Res. 2018. PMID: 30117186 Free PMC article.
References
-
- Hansson G. K. Inflammation, atherosclerosis, and coronary artery disease. The New England journal of medicine 352, 1685–1695 (2005). - PubMed
-
- Weber C. & Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17, 1410–1422 (2011). - PubMed
-
- Libby P. Inflammation in atherosclerosis. Nature 420, 868–874 (2002). - PubMed
-
- Hansson G. K. & Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6, 508–519 (2006). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous